Safety Study of TPX-121 on Nasolabial Folds

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 11, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions

Nasolabial Fold, Hypoplastic

Interventions

BIOLOGICAL

TPX-115(allogeneic fibroblasts)

Intradermal injection of TPX-115(allogeneic fibroblasts)

Trial Locations (1)

Kyungpook National University, School of Medicine, Daegu

All Listed Sponsors

lead

Tego Science, Inc.

INDUSTRY

NCT06533540 - Safety Study of TPX-121 on Nasolabial Folds | Biotech Hunter | Biotech Hunter